RC 01
Alternative Names: RC-01; T 1228Latest Information Update: 28 Mar 2023
At a glance
- Originator FUJIFILM Toyama Chemical
- Developer FUJIFILM Toyama Chemical; Recida Therapeutics
- Class Antibacterials
- Mechanism of Action LpxC inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Respiratory tract infections
Most Recent Events
- 28 Mar 2023 No recent reports of development identified for preclinical development in Bacterial-infections in Japan (IV, Injection)
- 28 Mar 2023 No recent reports of development identified for preclinical development in Respiratory-tract-infections in Japan (Inhalation)
- 28 Mar 2023 No recent reports of development identified for preclinical development in Respiratory-tract-infections in USA (Inhalation)